Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2009 063 028.8 |
96 | EP file number | EAKZ | 17 17 0017.2 |
97 | EP publication number | EPN | 3235491 |
54 | Designation/title | TI | VERZEHRBARE MARKER UND SYSTEM FÜR MULTIMODALE KOMMUNIKATIONSEREIGNISSE |
51 | IPC main class | ICM (ICMV) | A61K 9/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | G08B 1/08 (2006.01), G08B 13/14 (2006.01), G06K 5/00 (2006.01), A61M 31/00 (2006.01), A61B 5/07 (2006.01), A61B 5/00 (2006.01) |
22 | DE application date | DAT | Mar 5, 2009 |
96 | EP application date | EAT | Mar 5, 2009 |
43 | Date of first publication | OT | Oct 25, 2017 |
| Date of publication of grant | PET | Nov 4, 2020 |
71/73 | Applicant/owner | INH | Otsuka Pharmaceutical Co., Ltd., Tokyo, JP |
72 | Inventor | IN | ROBERTSON, Timothy, Belmont, California 94002, US; ZDEBLICK, Mark J., Portola Valley, California 94028, US |
74 | Representative | VTR | Murgitroyd Germany Patentanwaltsgesellschaft mbH, 80636 München, DE |
| Address for service | | Murgitroyd Germany Patentanwaltsgesellschaft mbH, 80636 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 34085 P Mar 5, 2008
|
| Due date | FT FG | Mar 31, 2026 Annual fee for the 18th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003235491A1 Searchable text:
EP000003235491A1 Original document:
EP000003235491B1 Searchable text:
EP000003235491B1 |
43 | Date of first publication | EVT | Oct 25, 2017 |
| Date of the first transfer into DPMAregister | EREGT | Oct 26, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 25, 2025 (Show all update days)(Hide all update days)- Jun 25, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 04.11.2020: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 04.11.2020: deleted
- Feb 28, 2025
- Sep 19, 2024
- St.36: changed (technical change)
- Oct 26, 2017
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 22, 2021 |
| Issue number | HN | 17 |
| Year | PJ | 2021 |
| Publication date | VT | Apr 29, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Otsuka Pharmaceutical Co., Ltd., Tokyo, JP |
71/73 | Previous applicant/owner | INHF | Proteus Digital Health, Inc., Redwood City, Calif., US |
| Date of update of the procedure | REGT | Apr 9, 2021 |